Author: BusinessWire

Overall survival of nearly 4 years in two patients with disappearance of ascites, normal liver function, and good quality of life
PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company…

–(BUSINESS WIRE)–#biopharmaceutical–Hope Biosciences Stem Cell Research Foundation, administered through the Greater Houston Community Foundation, was founded to address the need to accelerate translational research in regenerative medicine so that …

On Track to Complete Business Combination with Vesper Healthcare in the First Half of 2021
MIAMI BEACH, Fla. & LONG BEACH, Calif.–(BUSINESS WIRE)–The HydraFacial® Company (“HydraFacial,” or the “Company”), a category-creating beauty health company, …

DUBLIN–(BUSINESS WIRE)–The “Cephalosporin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added to ResearchAndMarkets.com’s offering.

The global cephalosporin market reached a value of US$ 17….

DUBLIN–(BUSINESS WIRE)–The “Cephalosporin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added to ResearchAndMarkets.com’s offering.

The global cephalosporin market reached a value of US$ 17….

— Analyses of long-term study with Givinostat in Duchenne Muscular Dystrophy boys continue to show delayed disease progression —

— EPYDIS Phase 3 pivotal clinical trial continues as planned with preliminary results expected in second quarter of 20…

DUBLIN–(BUSINESS WIRE)–The “Anti-CD30 Therapies – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering.

This report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Anti-CD30 therapi…

DUBLIN–(BUSINESS WIRE)–The “Anti-CD30 Therapies – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering.

This report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Anti-CD30 therapi…

Anthony Nolan Cell & Gene Therapy Services will provide umbilical cord blood and cord-derived NK cells to facilitate the development of ONK Therapeutics’ next-generation dual-targeted NK cell therapies

Collaboration supports a common mission to…

Solensia is the first injectable monoclonal antibody (mAb) licensed for alleviation of pain associated with osteoarthritis (OA) in cats

Solensia works as a monthly treatment targeting Nerve Growth Factor (NGF), a key player in OA pain

European C…